This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Platelet Activity in Vascular Surgery for Thrombosis and Bleeding (PIVOTAL)

This study is currently recruiting participants.
See Contacts and Locations
Verified January 2017 by New York University School of Medicine
Sponsor:
Collaborator:
American Heart Association
Information provided by (Responsible Party):
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT01897103
First received: July 8, 2013
Last updated: January 23, 2017
Last verified: January 2017
  Purpose
The proposed PIVOTAL study will examine a panel of platelet/coagulation activity markers during the perioperative period. The goal is to develop a clinically useful assessment of platelet/coagulation activity for risk stratification that may ultimately serve as a target for therapeutic intervention. This study will enroll 200 patients with peripheral artery disease undergoing vascular surgery. PIVOTAL is funded by American Heart Association and is scheduled to begin enrollment in July 2013 for approximately two years.

Condition
Peripheral Vascular Disease Peripheral Artery Disease Carotid Stenosis Aortic Aneurysm, Abdominal Aortic Aneurysm, Thoracic Amputation, Wound Embolism and Thrombosis Aortic Aneurysm

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Platelet Activity in Vascular Surgery

Resource links provided by NLM:


Further study details as provided by New York University School of Medicine:

Primary Outcome Measures:
  • Platelet Activity [ Time Frame: two years ]
    The main outcome measures are platelet activity, coagulation markers, platelet mapping and profiling.


Secondary Outcome Measures:
  • Perioperative Events [ Time Frame: Two-years ]
    Thrombotic and Bleeding events


Biospecimen Retention:   Samples With DNA
serum, plasma, platelet RNA

Estimated Enrollment: 200
Study Start Date: June 2013
Estimated Study Completion Date: August 2018
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Detailed Description:

To describe platelet activity among PAD subjects undergoing vascular surgery.

To determine whether preoperative platelet activity measurements are independently associated with perioperative cardiovascular events.

To identify demographic, clinical, and surgical factors associated with postoperative platelet activity measurements in patients with established PAD.

  Eligibility

Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Study Population will be selected from the inpatient setting at NYU Medical Center and Bellevue Hospital as well as the outpatient setting in the Faculty Group Practice.
Criteria

Inclusion Criteria:

  • Subjects undergoing non emergent vascular surgery
  • Use of aspirin within 48 hours prior to surgery
  • Age > 21 years of age
  • Able and willing to provide written informed consent for the study

Exclusion Criteria:

  • Use of any anticoagulant (Coumadin, heparin) within 24 hours to surgery
  • Use of any Nonsteroidal Antiinflammatory Drug (NSAID) (such as ibuprofen, naproxen, etc.) within 72 hours
  • Thrombocytopenia (platelet count<100) or Thrombocytosis (platelet count>500),
  • Anemia (hemoglobin<9),
  • Severe kidney disease (CrCl<30ml/min),
  • Any known hemorrhagic diathesis.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01897103

Contacts
Contact: Maya Rubin 646-501-2735 maya.rubin@nyumc.org
Contact: Edna Bissoon 212-263-4172 edna.bissoon@nyumc.org

Locations
United States, New York
Bellevue Hospital Center, South Manhattan Healthcare Network Recruiting
New York, New York, United States, 10016
Contact: Maya Rubin    646-501-2735    maya.rubin@nyumc.org   
Contact: Edna Bissoon, BA    212-263-4172    edna.bissoon@nyumc.org   
Principal Investigator: Jeffrey Berger, MD, MS, FAHA, FACC         
Sub-Investigator: Caron Rockman, MD         
Sub-Investigator: Adriana Perez, MD         
Sub-Investigator: Rubin Maya, BA         
Sub-Investigator: Derya Unutmaz         
Sub-Investigator: Jacqueline Bott, RN         
New York University School Of Medicine Recruiting
New York, New York, United States, 10016
Contact: Maya Rubin    646-501-2735    maya.rubin@nyumc.org   
Contact: Edna Bissoon, BA    212-263-4172    edna.bissoon@nyumc.org   
Sub-Investigator: Caron Rockman, MD         
Sub-Investigator: Derya Unutmaz, MD         
Sub-Investigator: Adriana Perez, MD         
Sub-Investigator: Jacqueline Bott, RN         
Sub-Investigator: Maya Rubin, BA         
Sponsors and Collaborators
New York University School of Medicine
American Heart Association
Investigators
Principal Investigator: Jeffrey S Berger, MD, MS, FAHA, FACC New York University School of Medicine
  More Information

Publications:
Responsible Party: New York University School of Medicine
ClinicalTrials.gov Identifier: NCT01897103     History of Changes
Other Study ID Numbers: 12-03123
Study First Received: July 8, 2013
Last Updated: January 23, 2017

Keywords provided by New York University School of Medicine:
Peripheral Artery Disease
Endarterectomy (Carotid)
Aortic Aneurysm, Abdominal
Aortic Aneurysm, Thoracic
Amputation
Platelet Activity
Thrombin
Transcriptomics

Additional relevant MeSH terms:
Aneurysm
Thrombosis
Embolism
Vascular Diseases
Aortic Aneurysm
Peripheral Arterial Disease
Peripheral Vascular Diseases
Carotid Stenosis
Aortic Aneurysm, Abdominal
Embolism and Thrombosis
Aortic Aneurysm, Thoracic
Cardiovascular Diseases
Aortic Diseases
Atherosclerosis
Arteriosclerosis
Arterial Occlusive Diseases
Carotid Artery Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on September 21, 2017